

Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week.
You can purchase shares of Surrozen (NASDAQ:SRZN) through any online brokerage.
Other companies in Surrozen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Surrozen has a consensus price target of $46.33.
The stock price for Surrozen (NASDAQ: SRZN) is $27.025 last updated October 26, 2026 at 1:15 PM EDT.
There are no upcoming dividends for Surrozen.
Surrozen does not have any upcoming earnings scheduled.
There is no upcoming split for Surrozen.
Surrozen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product...